Goodbody Health Statistics
Total Valuation
Goodbody Health has a market cap or net worth of 36.
| Market Cap | 36 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Goodbody Health has 36.50 million shares outstanding.
| Current Share Class | 36.50M |
| Shares Outstanding | 36.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.13% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.25 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -415.24 |
Financial Efficiency
Return on equity (ROE) is -55.54% and return on invested capital (ROIC) is -16.97%.
| Return on Equity (ROE) | -55.54% |
| Return on Assets (ROA) | -13.33% |
| Return on Invested Capital (ROIC) | -16.97% |
| Return on Capital Employed (ROCE) | -34.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.86 |
| Inventory Turnover | 14.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is 62.89, so Goodbody Health's price volatility has been higher than the market average.
| Beta (5Y) | 62.89 |
| 52-Week Price Change | -99.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 21,543 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, Goodbody Health had revenue of 18.35 million and -4.15 million in losses. Loss per share was -0.11.
| Revenue | 18.35M |
| Gross Profit | 9.02M |
| Operating Income | -2.11M |
| Pretax Income | -4.07M |
| Net Income | -4.15M |
| EBITDA | -1.76M |
| EBIT | -2.11M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 3.40 million in cash and 154,818 in debt, giving a net cash position of 3.24 million or 0.09 per share.
| Cash & Cash Equivalents | 3.40M |
| Total Debt | 154,818 |
| Net Cash | 3.24M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 6.08M |
| Book Value Per Share | 0.17 |
| Working Capital | 2.43M |
Cash Flow
In the last 12 months, operating cash flow was -751,780 and capital expenditures -355,943, giving a free cash flow of -1.11 million.
| Operating Cash Flow | -751,780 |
| Capital Expenditures | -355,943 |
| Free Cash Flow | -1.11M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 49.13%, with operating and profit margins of -11.49% and -22.61%.
| Gross Margin | 49.13% |
| Operating Margin | -11.49% |
| Pretax Margin | -22.20% |
| Profit Margin | -22.61% |
| EBITDA Margin | -9.57% |
| EBIT Margin | -11.49% |
| FCF Margin | n/a |
Dividends & Yields
Goodbody Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.29% |
| Shareholder Yield | -10.29% |
| Earnings Yield | -11,527,941.67% |
| FCF Yield | -3,077,008.33% |
Stock Splits
The last stock split was on August 22, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 22, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Goodbody Health has an Altman Z-Score of 2.44. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.44 |
| Piotroski F-Score | n/a |